Biggest News Aggregation in the World
📰 Milestone Payment News

Page 4 - Milestone Payment News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Milestone Payment. Real-time updates on events, politics, business and more.

Nascent Biotech Inc.: Nascent Biotech Receives $750k Milestone Payment from BioRay Pharmaceutical

Milestone Payment is the Second of Four in $5M Pritumumab Licensing DealVERO BEACH, FL / ACCESSWIRE / February 23, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company")
United States Kostenloser Wertpapierhandel Sean Carrick Exchange Commission Bioray Pharmaceutical Ltd Nascent Biotech Inc

Aardvark Capital Corp.: Aardvark Capital and 2766604 Ontario Ltd. Execute Business Combination Agreement for Proposed Qualifying Transaction and Announce Upsizing of Previously Announced Private Placement of Subscription Receipts

Toronto, Ontario--(Newsfile Corp. - December 24, 2021) - Aardvark Capital Corp. (TSXV: ACCA.P) (the "Company") and 2766604 Ontario Ltd. ("GoldCo", and together with the Company, the "Parties") are pleased
United States United Kingdom Battle Mountain Christina Mccarthy Zachary Goldenberg Kostenloser Wertpapierhandel

Basilea Pharmaceutica AG: Basileas Partner Asahi Kasei Pharma reicht Antrag auf Marktzulassung (NDA) von Isavuconazol in Japan ein

Ad hoc-Mitteilung gemäss Art. 53 KR Basel, 30. September 2021 Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass ihr Partner Asahi Kasei Pharma Corporation (Asahi Kasei Pharma) in Japan
United States Sher Corporation Services Or Achievements Of Basilea S Partnership Swiss Exchange Market Approval

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Tagesausblick für 04.08.: DAX bleibt lustlos. Green Technologies sowie Daten aus China und USA im Fokus!

Tagesausblick für 04.08.: DAX bleibt lustlos. Green Technologies sowie Daten aus China und USA im Fokus! HypoVereinsbank onemarkets Der Handel an den internationalen Aktienmärkten blieb heute trotz des Datenreigens lustlos. Einzig der französische CAC40 setzte den Aufwärtstrend fort. In den USA sind die Auftragseingänge in der Industrie zwar gestiegen. Kaufimpulse löste diese Nachricht an der Wall Street dennoch nicht aus. So schloss der DAX wenig verändert bei 15.560 Punkten und der Eur...
Index Services A Securities Prospectus Institute For Financial Services Or Downward Movement Hypovereinsbank Of Commercially Stock Markets

Tagesausblick für 04.08.: DAX bleibt lustlos. Green Technologies sowie Daten aus China und USA im Fokus! ()

04.08.21 09:44 Der Handel an den internationalen Aktienmärkten blieb heute trotz des Datenreigens lustlos. Einzig der französische CAC®40 setzte den Aufwärtstrend fort. In den USA sind die Auftragseingänge in der Industrie zwar gestiegen. Kaufimpulse löste diese Nachricht an der Wall Street dennoch nicht aus. So schloss der DAX® wenig verändert bei 15.560 Punkten und der EuroStoxx®50 bei 4.120 Punkten. Morgen kommen zahlreiche Wirtschaftsdaten aus China und den USA, welche die Märkte ...
Institute For Financial Services Oil Price A Securities Prospectus Index Services Or Downward Movement Stock Markets

Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases

Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION THIS ANNOUNCEMENT IS BEING MADE PURSUANT TO RULE 2.5 OF THE IRISH TAKEOVER RULES FOR IMMEDIATE RELEASE Transactio...
New York United States District Of Columbia State Of New York Jeffreyw Sherman Strongbridge Rsus

Neuropore Therapeutics Gets $20M Milestone Payment

socaltech.com San Diego-based Neuropore Therapies, which is developing treatments for Parkinsons disease, reported today that it has received $20M in a milestone payment from UCB. Neuropore Therapeutics said the payment is related to its collaboration with UCB and the evaluation of UCB0599 for the treatment of Parkinsons Disease. Doug Bonhaus is President and CEO of Neuropore Therapies. UCB is based in Belgium.
Therapeutics Gets Milestone Payment Diego Based Neuropore Therapies Doug Bonhaus Life Science சிகிச்சை பெறுகிறது

HempFusion Signs Definitive Agreement to Acquire Pioneering CBD Brand Apothecanna

HempFusion Signs Definitive Agreement to Acquire Pioneering CBD Brand Apothecanna HempFusion Wellness Inc. a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce it has entered into a Purchase Agreement to acquire 100% interest in APCNA Holdings LLC . Established in 2009, Apothecanna pioneered cannabis-powered body care and topicals, and was the first topicals brand to expand nationally and obtain a Federal Trademark. …...
United States Jeff Henretig Jason Mitchell Company Hempfusion Hempfusion Wellness Inc Hempfusion Co

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science